Matches in Wikidata for { <http://www.wikidata.org/entity/Q34549725> ?p ?o ?g. }
- Q34549725 description "2004 nî lūn-bûn" @default.
- Q34549725 description "2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած" @default.
- Q34549725 description "2004 թվականի հուլիսին հրատարակված գիտական հոդված" @default.
- Q34549725 description "2004年の論文" @default.
- Q34549725 description "2004年論文" @default.
- Q34549725 description "2004年論文" @default.
- Q34549725 description "2004年論文" @default.
- Q34549725 description "2004年論文" @default.
- Q34549725 description "2004年論文" @default.
- Q34549725 description "2004年论文" @default.
- Q34549725 description "2004年论文" @default.
- Q34549725 description "2004年论文" @default.
- Q34549725 description "2004年论文" @default.
- Q34549725 description "2004年论文" @default.
- Q34549725 description "2004年论文" @default.
- Q34549725 description "2004년 논문" @default.
- Q34549725 description "article científic" @default.
- Q34549725 description "article scientific" @default.
- Q34549725 description "article scientifique (publié 2004)" @default.
- Q34549725 description "articol științific" @default.
- Q34549725 description "articolo scientifico" @default.
- Q34549725 description "artigo científico (publicado na 2004)" @default.
- Q34549725 description "artigo científico (publicado na 2004)" @default.
- Q34549725 description "artigo científico" @default.
- Q34549725 description "artikull shkencor" @default.
- Q34549725 description "artikulong pang-agham" @default.
- Q34549725 description "artykuł naukowy" @default.
- Q34549725 description "artículo científico publicado en 2004" @default.
- Q34549725 description "artículu científicu espublizáu en 2004" @default.
- Q34549725 description "bilimsel makale" @default.
- Q34549725 description "bài báo khoa học" @default.
- Q34549725 description "mokslinis straipsnis" @default.
- Q34549725 description "naučni članak" @default.
- Q34549725 description "scienca artikolo" @default.
- Q34549725 description "scientific article" @default.
- Q34549725 description "teaduslik artikkel" @default.
- Q34549725 description "tieteellinen artikkeli" @default.
- Q34549725 description "tudományos cikk" @default.
- Q34549725 description "vedecký článok" @default.
- Q34549725 description "vetenskaplig artikel" @default.
- Q34549725 description "videnskabelig artikel (udgivet 2004)" @default.
- Q34549725 description "vitenskapelig artikkel" @default.
- Q34549725 description "vitskapeleg artikkel" @default.
- Q34549725 description "vědecký článek" @default.
- Q34549725 description "wetenschappelijk artikel" @default.
- Q34549725 description "wissenschaftlicher Artikel" @default.
- Q34549725 description "επιστημονικό άρθρο" @default.
- Q34549725 description "мақолаи илмӣ" @default.
- Q34549725 description "мақолаи илмӣ" @default.
- Q34549725 description "наукова стаття, опублікована в липні 2004" @default.
- Q34549725 description "научна статия" @default.
- Q34549725 description "научная статья" @default.
- Q34549725 description "научни чланак" @default.
- Q34549725 description "научни чланак" @default.
- Q34549725 description "מאמר מדעי" @default.
- Q34549725 description "سائنسی مضمون" @default.
- Q34549725 description "مقالة علمية" @default.
- Q34549725 description "مقالهٔ علمی" @default.
- Q34549725 description "২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q34549725 description "บทความทางวิทยาศาสตร์" @default.
- Q34549725 description "სამეცნიერო სტატია" @default.
- Q34549725 name "The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle" @default.
- Q34549725 name "The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle" @default.
- Q34549725 name "The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle" @default.
- Q34549725 type Item @default.
- Q34549725 label "The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle" @default.
- Q34549725 label "The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle" @default.
- Q34549725 label "The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle" @default.
- Q34549725 prefLabel "The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle" @default.
- Q34549725 prefLabel "The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle" @default.
- Q34549725 prefLabel "The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle" @default.
- Q34549725 P1433 Q34549725-3B7BCE78-F07E-4C41-B0DD-5BF939C32913 @default.
- Q34549725 P1476 Q34549725-532DB3DE-D76A-4AC9-8EB1-A1D141EA1C10 @default.
- Q34549725 P2093 Q34549725-10DAF100-0D97-4A89-890C-5937C75E3081 @default.
- Q34549725 P2093 Q34549725-278BEB49-5153-47DA-814E-A5F7CE2D89DB @default.
- Q34549725 P2093 Q34549725-2B28C6EC-9404-4625-9187-78B6953244B1 @default.
- Q34549725 P2093 Q34549725-3B16A2A5-2721-4315-A753-B07590543D4B @default.
- Q34549725 P2093 Q34549725-73F59F83-CEF5-41E1-AFCE-C39988579FA5 @default.
- Q34549725 P2093 Q34549725-79C7433B-5D44-48DF-8B8F-1F87F2DEC516 @default.
- Q34549725 P2093 Q34549725-AEC7700F-7FE4-4853-B3F9-EFB8C43D78C0 @default.
- Q34549725 P2093 Q34549725-C772DBEE-F207-4C94-BCA4-F81028BAF46D @default.
- Q34549725 P2093 Q34549725-EAD4C95D-E6B2-4B8E-A955-AB77B1BAD5D8 @default.
- Q34549725 P2093 Q34549725-F89678C8-5516-41D2-9CDE-AFBA323A20A0 @default.
- Q34549725 P304 Q34549725-8089F2F7-7D13-4F14-9CBC-889C9B5A95EF @default.
- Q34549725 P31 Q34549725-3063E203-03B9-4B52-978F-A6A9C0A3BF4C @default.
- Q34549725 P356 Q34549725-5B36B8C8-CF99-40C0-AFAF-05D5FCD11063 @default.
- Q34549725 P407 Q34549725-8725F68A-DE2A-4928-A408-EFA3203806D9 @default.
- Q34549725 P433 Q34549725-CA2BCF59-2C67-4B5F-8022-FEEC09B8D248 @default.
- Q34549725 P478 Q34549725-80C373DF-5306-4A60-8B04-CBD1C9D71E76 @default.
- Q34549725 P50 Q34549725-0FF0ACDE-21C1-49EA-81DF-494EB237AC84 @default.
- Q34549725 P50 Q34549725-33C155C5-19A8-49F1-8659-7173370AE03B @default.
- Q34549725 P50 Q34549725-3C81A8DA-F6E9-4D9A-ACEA-610898F4BEC5 @default.
- Q34549725 P50 Q34549725-400B58B5-7868-4F69-84CB-D5783DAB70E9 @default.
- Q34549725 P50 Q34549725-8D9F5CB0-C623-4589-8B50-D2F0CD215940 @default.
- Q34549725 P50 Q34549725-EC8E7866-DEFE-47E0-BE70-6563E5344015 @default.
- Q34549725 P577 Q34549725-21D34448-F072-4A48-83B6-F722629615B0 @default.
- Q34549725 P5875 Q34549725-CCD30177-FD48-4C65-9955-8D7B6955F2FF @default.
- Q34549725 P698 Q34549725-0E417A20-52AC-4984-8358-8E6E38B3D588 @default.
- Q34549725 P921 Q34549725-33BD0B82-E6CC-4E9D-811C-A751A453FAB6 @default.
- Q34549725 P921 Q34549725-EEADD3F5-85A0-493A-87AB-01997B53461D @default.